Firstranker's choice
Roll No.
--- Content provided by FirstRanker.com ---
Total No. of Pages : 01
Total No. of Questions : 06
M.Pharmacy (Pharmaceutics) (2017 & Onwards) (Sem.-1)
REGULATORY AFFAIRS
Subject Code : MPH-104T
--- Content provided by FirstRanker.com ---
M.Code: 74660
Time: 3 Hrs.
Max. Marks: 75
INSTRUCTIONS TO CANDIDATES :
- Attempt any FIVE questions out of SIX questions.
- Each question carry FIFTEEN marks.
--- Content provided by FirstRanker.com ---
-  a) What are generic products? When can generics be marketed? Outline the process for obtaining approval for marketing generics. 
 b) What is NDA? Outline the NDA approval process.
-  a) How are bioequivalence studies conducted? Mention the ICH requirements for products to be declared bioequivalent. 
 b) Clarify the role of CROs in bioequivalence testing.
-  a) What is eCTD? What are the advantages of filing eCTD? 
 b) Briefly explain the non-clinical investigations process.
-  a) What is meant by "informed consent"? What is the role of informed consent in drug approval? 
 b) Explain IMPD dossier.
-  a) Write briefly about the ICH regulations pertaining to Safety. --- Content provided by FirstRanker.com --- b) What is meant by pharmacovigilance? Explain the ICH requirements and outcomes of pharmacovigilance.
-  Write short notes on: 
 a) HIPAA
 b) SUPAC guidelines
 c) Regulations for novel therapies
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
NOTE : Disclosure of Identity by writing Mobile No. or Marking of passing request on any paper of Answer Sheet will lead to UMC against the Student.
1 | M-74660
--- Content provided by FirstRanker.com ---
This download link is referred from the post: PTU M.Pharm 1st Semester Last 10 Years 2011-2021 Previous Question Papers|| Punjab Technical University
